I-Mab Biopharma
IMAB
#9469
Rank
โ‚น4.73 B
Marketcap
โ‚น58.13
Share price
-6.87%
Change (1 day)
-61.87%
Change (1 year)

I-Mab Biopharma (IMAB) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น15.76 Billion

According to I-Mab Biopharma's latest financial reports the company has โ‚น15.76 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

I-Mab Biopharma - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น3.79 B-36.72%
2022-12-31โ‚น5.99 B-23.46%
2021-12-31โ‚น7.83 B-4.67%
2020-12-31โ‚น8.22 B381.86%
2019-12-31โ‚น1.70 B-37.4%
2018-12-31โ‚น2.72 B215.8%
2017-12-31โ‚น0.86 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น1.40 B-91.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น36.92 B 134.25%๐Ÿ‡บ๐Ÿ‡ธ USA